31,35-37 Prospective trials are needed to further explore this potential adverse event and worsened DR, which is the central premise of the ophthalmic FOCUS trial that is expected to release results in 2026
This dual mechanism distinguishes Tirzepatide from earlier GLP-1 receptor agonists by targeting complementary metabolic pathways involved in glucose regulation, appetite control and energy homeostasis
Therapeutic Class Vitamin & Nutritional Supplement Action Class Nutritional & antioxidant supplement Chemical Class Antioxidants, vitamins, minerals, amino acid derivatives Habit Forming No PlatinumRx is committed to providing reliable and accurate information to support informed customer decisions
Cons: Sometimes small portions, wide range of calories 500-1,000, consistently pretty high in sodium and saturated fats (hence why they are so tasty!)
Key Takeaways Semaglutide acts only on GLP-1 receptors, while tirzepatide targets both GLP-1 and GIP, a dual mechanism that sets them apart